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Abstract. Genes for the human a5(IV) and o~6(IV) col- 
lagen chains have a unique arrangement in that they 
are colocalized on chromosome Xq22 in a head-to-head 
fashion and appear to share a common bidirectional 
promoter. In addition we reported a novel observation 
that the COL4A6 gene is transcribed from two alterna- 
tive promoters in a tissue-specific manner (Sugimoto, 
M., T. Oohashi, and Y. Ninomiya. 1994. Proc. Natl. 
Acad. Sci. USA. 91:11679-11683). To know whether the 
translation products of both genes are colocalized in 
various tissues, we raised a5(IV) and a6(IV) chain-spe- 
cific rat monoclonal antibodies against synthetic pep- 
tides reflecting sequences near the carboxy terminus of 
each noncollagenous (NC)I domain. By Western blot- 
ting a6(IV) chain-specific antibody recognized 27-kD 
monomers and associated dimers of the human type IV 
collagen NC1 domain, which is the first demonstration 
of the presence in tissues of the ot6(IV) polypeptide as 
predicted from its cDNA sequence. Immunofluores- 
cence studies using anti-oL6(IV) antibody demonstrated 
that in human adult kidney the tx6(IV) chain was never 
detected in the glomerular basement membrane, 
whereas the basement membranes of the Bowman's 
capsules and distal tubules were positive. The staining 
pattern of the glomerular basement membrane was 
quite different from that obtained with the anti-o~5(IV) 
peptide antibody. The o~5(IV) and a6(IV) chains were 
colocalized in the basement membrane in the skin, 
smooth muscle cells, and adipocytes; however, little if 
any reaction was seen in basement membranes of car- 
diac muscles and hepatic sinusoidal endothelial cells. 
Thus, both genes are expressed in a tissue-specific man- 
ner, perhaps due to the unique function of the bidirec- 
tional promoter for both genes, which is presumably 
different from that for COL4A1 and COL4A2. 
B 
ASEMENT membranes are continuous sheets of spe- 
cialized extracellular matrix composed of collagen 
IV, laminin, nidogen, heparan sulphate proteogly- 
can, and other glycoproteins that are found wherever cells 
meet  extracellular matrix  (Rohrbach  and  Timpl,  1993). 
This means that basement membranes are located outside 
of most of the cells:  at the dermal-epithelial junction; at 
the base  of all lining epithelia throughout the digestive, 
respiratory, reproductive,  and urinary tracts;  underlying 
endothelia  of  capillaries  and  venules;  around  Schwann 
cells,  adipocytes,  skeletal,  cardiac,  and  smooth  muscle 
cells; and at the base of parenchymatous exocrine and en- 
docrine glands (Junqueira et al., 1992). Thus, they are the 
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natural substrates on which most of the cells except blood 
cells grow and develop. They closely adjoin and are prod- 
ucts of the overlying cells, and serve to compartmentalize 
the  extracellular matrix  and  provide  a  barrier  between 
cells and matrix. 
Collagen type IV is  a  major structural component of 
basement membrane. The major form of this protein is a 
heterotrimer  containing ed(IV)  and  ot2(IV)  chains, and 
this form appears to be ubiquitous in all basement mem- 
branes (Rohrbach and Timpl, 1993).  Microsequencing of 
peptides made it possible to identify the human tx3(IV) 
and et4(IV) chains (Wieslander et al., 1985; Butkowski et 
al.,  1990).  The  primary structure  of the  human a3(IV) 
chain has been reported just recently (Mariyama et al., 
1994)  and  cDNAs  encoding  the  entire  human  a4(IV) 
chain have been isolated and characterized as well (Sugi- 
moto et al., 1994; Leinonen et al., 1994). Lately, the nature 
of the tx5(IV) chain has been identified by cDNA isolation 
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tween the e~5(IV) gene (COL4A5) and Alport's Syndrome 
has been clarified (Barker et al., 1990).  Zhou et al. (1993) 
and Oohashi et al. (1994)  cloned genomic DNA and cDNAs 
coding for yet another c~(IV) chain, cx6(IV).  These newly 
discovered c~ chains still contain the amino-terminal 7S do- 
main, the central COL1 domain, and the carboxy-terminal 
noncollagenous  (NC)I n domain  (Oohashi  et  al.,  1994)  as 
found in the classical cd(IV) and a2(IV) chains; however 
we do not know the mechanism to explain which of the six 
c~ chains are selected, or how they come together, to form 
collagen type IV molecules. 
Of interest is that the genes encoding the six individual 
c~ chains  in humans are paired by two on three  different 
chromosomes: the cxl(IV) gene (COL4A1) and the e~2(IV) 
gene (COL4A2) are located on chromosome 13 (Pihlaja- 
niemi et al.,  1985;  Boyd et al.,  1988;  Griffin et al.,  1987); 
COL4A3 and COL4A4 are on chromosome 2 (Mariyama 
et  al.,  1994;  Kamagata  et  al.,  1992);  and  COL4A5  and 
COL4A6  are  on  chromosome  X  (Hostikka et  al.,  1990; 
Zhou et al.,  1993; Oohashi et al., 1994).  Further, COL4A1 
and COL4A2 are aligned in a  head-to-head fashion shar- 
ing a common promoter between the two genes (Poschl et 
al.,  1988;  Soininen  et  al.,  1988),  whereas  the  precise  up- 
stream structure of COL4A3  and  COL4A4 has not been 
reported yet. COL4A5 and COL4A6 have been found to- 
gether on chromosome X at the segment q22 (Hostikka et 
al., 1990; Zhou et al., 1993; Oohashi et al., 1994)  and have 
been reported to be also arranged in a head-to-head fash- 
ion  and  to  share  a  bidirectional  promoter  (Zhou  et  al., 
1993).  Furthermore,  we  reported  the  novel  observation 
that  the  COL4A6 gene is transcribed from two alternate 
promoters  in  a  tissue-specific  fashion  (Sugimoto  et  al., 
1994). 
Presently we report for the first time the presence of the 
COL4A6  gene products as detected by Western  blotting 
and immunofluorescence staining of various tissues by use 
of  peptide-specific  monoclonal  antibodies.  Our  results 
demonstrate  that  the  COL4A5  and  COL4A6  genes  are 
not necessarily coexpressed in several types of tissues. 
Materials and Methods 
Synthetic Peptides 
Earlier  we  determined  the  complete  primary  structure  of the  human 
a6(IV) chain (Oohashi et al.,  1994; Zhou et al.,  1994). When the amino 
acid sequences of all six a(IV) chains were compared, their noncollage- 
nous  (NC)1  domain  portions showed the  highest homology with each 
other. However, the amino acid sequences of certain subregions of NC1 
were quite different from one another. We selected the peptide TI'VEER- 
QQFGELPVSETLKAGQLHTRV  from  the c~6(IV) chain  (Oohashi et 
al.,  1994)  and  ATVDVSDMFSKPQSETLKAGDLRTRIS  from  the 
e~5(IV) chain (Hostikka et al.,  1990), both of which are close to the car- 
boxyl ends, as shown in Fig.  1.  We  also synthesized a  peptide, CPST- 
GELEFMGFPKG, derived from the third imperfection of the GIy-X-Y 
repeating sequence in the COL1 domain of the c~6(IV) chain. A cysteinyl 
residue was added at the amino terminus to allow coupling of the peptide 
to the carrier protein. Oligopeptides were chemically synthesized by the 
solid-phase procedure of Merrifield (1963)  with the aid of an automated 
peptide synthesizer (model 430; Applied Biosystems, Inc., Foster City, 
CA). The synthetic peptides were conjugated to a carrier protein, keyhole 
1. Abbreviations  used in this paper: COL, collagen; KLH, keyhole limpet 
hemocyanin; NC, noncollagenous; PVDF, polyvinylidene difluoride. 
Figure 1.  Schematic representation of the two genes COL4A5 and 
COL4A6  on chromosome Xq22.  (Top)  COL4A5  and  COL4A6 
are  arranged  head-to-head  in  close  proximity  on  chromosome 
Xq22 (Sugimoto et al., 1994). Arrows indicate the direction of the 
transcripts for COL4A5  and COL4A6.  There are two transcrip- 
tions for COL4A6.  One transcription start site (from exon 1') for 
COL4A6  is  442  bp  away  from  the  transcription  start  site  of 
COL4A5, while an alternative transcription start site (from exon 
1)  is located 1050 bp apart  from the first one and drives the ex- 
pression of a second transcript that encodes an e~6(IV) chain with 
a  different signal peptide.  (Bottom)  Because  of the direction  of 
the  two  genes,  the  translation  products,  a5(IV)  and  c~6(IV) 
chains,  of the  two  genes  are  drawn  accordingly.  Chain-specific 
monoclonal  antibodies  were  raised  against  synthetic  peptides 
(short bars) of the NC1  domains close to the carboxyl termini of 
the two chains. The third peptide deduced from the third imper- 
fection of the Gly-X-Y repeating sequence in the central COL1 
domain was synthesized and used for monoclonal antibodies. The 
sequences  of the  three  synthetic  peptides  are  shown  with  cys- 
teinyl residues at the amino termini. Using the Geysen's peptide 
scanning technique (Geysen et al., 1987) we determined the exact 
location of the epitopes for H61, H62, and H63. Relative location 
of the epitopes are shown by three thick bars under the c~6(IV) 
peptide. 
limpet hemocyanin, by the maleimide method (Ishikawa et al.,  1983). In 
some experiments the peptides were directly used as antigen without con- 
jugation to hemocyanin, and the antigenic efficiency was found not to dif- 
fer  much.  Other  peptides,  ATIERSEMFKKPTPSTLKAGELRTHVS 
from  the  al(IV)  chain  (Pihlajaniemi  et  al_  1985),  TTIPEQSFQGSP- 
SADTLKAGLIRTHIS  from the e~2(IV) chain (Hostikka  and Tryggva- 
son,  1988),  ASLNPERMFRKPIPSTVKAGELEKIIS  from  the  c~3(IV) 
chain (Morrison et al., 1991), and TVKADFEFSSAPAPDTLKESQAQR- 
QKI from the c~4(IV) chain (Sugimoto et al.,  1993), were used for raising 
chain-specific antibodies against the other human c~ chains. 
Peptide-specifie  Monoelonal Antibodies 
We introduced new steps to our previous method and developed a new ef- 
ficient procedure, the rat lymph node method, for raising monoclonal an- 
tibodies (Kishiro et al., 1995). Briefly, WKY/NCrj rats (Charles River Ja- 
pan, Yokohama, Japan) were immunized in the hind foodpads with 50 mg 
of hemocyanin-coupled synthetic peptide emulsified with Freund's com- 
plete adjuvant. Three or four weeks later the rats were killed, and Iympho- 
cytes obtained from the medial iliac  lymph nodes of the rats were fused 
with mouse myeloma cells (SP2/0-Ag14). Supernatants from hybridoma 
cultures were screened by ELISA, using hemocyanin-free peptides from 
individual a(IV) chains. 
The initial screening was performed by EIISA with the synthetic pep- 
tides themselves and/or native NC1 fractions isolated from the human kid- 
ney and other peptides of the same region from all c~(IV) NCI  domains. 
2,000 clones were screened and we picked 145 positive clones that reacted 
specifically with the c~6(IV) peptide. The second screening was performed 
by indirect immunofluorescence using human tissue sections. Thus, three 
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and immunofluorescence were established. 
Preparation of the NC1-Domain Fraction  from 
Renal Basement Membrane 
Renal basement membrane was prepared by the  same method as that 
used for bovine renal basement membrane (Sado et al., 1991). In order to 
recover the NC1 domains from the collagen IV molecules we used bacte- 
rial  collagenase  and  removed  the  central  collagenous  (COL)  domains 
from the molecules. Namely, lyophilized  basement membrane was solubi- 
lized with collagenase (Seikagaku Kogyo, Tokyo, Japan) at 47°C for 20 h 
by a method similar to that used for bovine nephritogenic antigen. After 
solubilization,  the sample was centrifuged at 27,000 g for 10 min and insol- 
uble material was removed. The supernatant was dialyzed  against distilled 
water for 8 h, lyophilized,  dissolved in PBS,  and  dialyzed  against PBS 
overnight. The material was then centrifuged to remove insoluble materi- 
als formed during the dialysis. The supernatant was applied to a gel filtra- 
tion column of UltrogelAcA 34(26  x  950 ram) at a flow rate of 30 ml/h. 
The main peak fraction was coilected  and concentrated. 
Western Blotting 
The NC1  fractions of collagen type IV thus prepared were analyzed by 
SDS-polyacrylamide  gel  electrophoresis  under  nonreducing conditions 
(Laemmli, 1970). SDS-containing 5%  stacking and 11.5%  homogeneous 
running polyacrylamide slab gels  were used.  Proteins separated on the 
SDS gels were blotted onto polyvinylidene  difluoride  (PVDF) membranes. 
The membrane was incubated with the primary antibodies first and then 
with the peroxidase-conjugated secondary antibodies (Sado et al., 1991). 
Immunohistochemical Staining 
Indirect immunofluorescence staining were performed as described previ- 
ously (Sado et al., 1991). In the preliminary experiments we have tested 
different conditions varying the concentration of the urea, pH, incubation 
time, and temperature using the representative tissues including kidney, 
muscles, and skin. We set up to the standard acid-urea denaturation con- 
dition:  incubating ethanol-fixed sections with 6 M  urea-HC1  buffer (pH 
3.5) for 1 h at room temperature. 6 M urea treatment is necessary for most 
of the antibodies probably due to the linearized synthetic peptide  anti- 
gens. Control sections for immunofluorescence staining were reacted with 
nonimmnne rat sera or with the secondary antibody alone. These controls 
were negative. 
The staining method for the kidney and skin. Normal portions of human 
kidneys were obtained from two patients with renal tumors (both males, 
56 and 85 yr old). Renal biopsies were performed from two AIport's syn- 
drome patients (males, 14 and 9 yr old).  Skin  specimens were obtained 
from the patients with Alport's syndrome and from patients with non- 
renal diseases by surgical biopsy. 
The tissues from the kidney and skin were snap-frozen in liquid  nitro- 
gen. 3-ram cryosections were fixed with acetone for 10 min. To reveal pos- 
sible masked epitopes, we pretreated the sections with 6 M urea in 0.1 M 
glycine-HC1 buffer (pH 3.5) for 10 min at room temperature. After having 
been washed with PBS, the sections were incubated with monoclonal anti- 
bodies for 1 h at room temperature. After another washing with PBS, they 
were incubated with FITC-labeled goat anti-rat IgG (Cappel Labs., Coch- 
ranville,  PA) for 1 h, and then were examined under a fluorescence micro- 
scope (Axiophot, Zeiss, Germany). Control sections were treated by the 
same protocol except for the step of the incubation with the monoclonal 
antibody. 
The staining for the extrarenal tissues. Various  organs  obtained  from 
an autopsy case (64-yr-old  female) were used as normal tissues. Acid-urea 
denaturation was performed by incubating  acetone-fixed  sections with 0.1 M 
glycine-HCl  buffer (pH 3.5) containing 6 M urea for 2 to 30 min at room 
temperature. Positive  control sections were stained with anti-cd(IV) or 
a2(IV) collagen antibody, as it is well known that both al(IV) and a2(IV) 
chains are usually colocalized  in basement membrane. Negative control 
sections were reacted with non-immune rat sera, with the secondary anti- 
body alone, or with the primary antibody preabsorbed with the synthetic 
peptide. 
Alport's Syndrome Patients 
We examined two cases of Alport's syndrome diagnosed by clinical mani- 
festations and histological  examinations. One case,  a  14-yr-old  boy, had 
proteinuria, hearing loss, and eye lesions. Electron microscopic examination 
of the glomeruli showed basement membrane thickening with lamination 
and splitting. The second case, a 9-yr-old boy, had proteinuria (0.2~.6 g/d) 
and hematuria since the age of three years. He displayed farsightedness of 
the eyes and hearing loss as well. Several relatives had renal diseases, and 
some of them had died.  Histological and electron microscopic examina- 
tion of the kidney demonstrated irregular thickening of the glomerular 
basement membrane, confirming the diagnosis. 
Results 
Production of a6(IV) Chain-specific Antibodies 
We selected a relatively nonconserved region, close to the 
carboxy termini of the NC1 domains, as a pattern to pre- 
pare  synthetic peptides for use  as  immunogens to elicit 
a(IV) chain-specific monoclonal antibodies. Keyhole lim- 
pet hemocyanin (KLH)-conjugated peptide emulsified with 
Freund's complete adjuvant was  injected into hind foot- 
pads, and medial iliac lymph nodes of the immunized rat 
were  used  for  fusion  with  myeloma  cells.  For  a6(IV)- 
specific antibodies we repeated the cell fusion five times. 
In each experiment fused cells were plated on four 96-well 
plates.  145 positive wells from the five experiments were 
obtained by direct  reaction with  the  synthetic peptides. 
We further screened by staining frozen sections of human 
kidney  and  selected  12  strongly  positive  clones,  which 
were then tested with the synthetic peptides from the same 
region of the other cd through c~5 chains by ELISA. All of 
the 12 clones were specific for the a6(IV) chain. Three an- 
tibody clones out of these 12 clones for the ~6(IV) pep- 
tide, H61, H62, and H63, were established after subcloning 
by  limiting  dilution.  Monoclonal  antibodies  Hll,  H21, 
H31, H43, and H52 to the human cd(IV), R2(IV), ~3(IV), 
a4(IV),  and  a5(IV)  chains,  respectively, were  also  ob- 
tained in the study. Significant similarity was not found be- 
tween the peptide sequences used for antibodies and the 
known amino acid sequence in proteins by DDBJ or Swiss 
Plot sequence analysis. The specificity of the  antibodies 
against the synthetic peptides was tested by ELISA. A typ- 
ical specific reaction of each antibody to individual antigen 
peptides is demonstrated in Fig. 2. Using the Geysen pep- 
tide  scanning  technique  (Geysen  et  al.,  1987),  we  nar- 
rowed down the epitopes for H61, H62, and H63 to the 
amino acid sequences of VSETLK, FGEL, and GELP, re- 
spectively, within the synthetic peptide sequence. Relative 
location of the epitopes for H61, H62, and H63 is drawn in 
Fig. 1. 
Immunoblot Analysis 
The structure of the entire human et6(IV) collagen poly- 
peptide was predicted by cDNA sequence analysis  (Oo- 
hashi et al., 1994). The deduced collagen polypeptide con- 
tained  1690  amino  acid  residues,  including  a  21-residue 
signal peptide, a 24-residue amino-terminal NC domain, a 
central  1417-residue collagenous (COL1) domain,  and  a 
228-residue carboxy-terminal NC1 domain. To detect the 
presumptive peptide at the protein level we utilized mono- 
clonal antibody H63, specific for the eDNA-derived poly- 
peptide that was mentioned above. Kidney was used as the 
starting material for Western blotting analysis. Since the 
predicted ~t6(IV) collagen polypeptide structure was simi- 
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a(IV) chain-specific antibodies. 
(A) The carboxy-terminal ~40 
amino  acid  residues  of  the 
c~l  (IV), a2(IV), a3(IV), a4(IV), 
od(IV), and a6(IV) chains are 
aligned to  have  the  maximum 
homology. Dashes indicate the 
amino acid residues that are the 
same  as for the al(IV) chain. 
Gaps  (-)  are  introduced  to 
maintain alignment. The amino 
acid sequences of peptides used 
as immunogens for c~ chain-spe- 
cific monoclonal antibodies are 
indicated by the shaded area. (B) The synthetic peptides used as immunogens for c~ chain-specific monoclonal antibodies were fixed onto 
the well bottoms of a 96-well plate. Top row: Control, only bovine serum albumin; second row: al(IV) peptide; third row: a2(IV) peptide; 
fourth row: e~3(IV) peptide; fifth row: e~4(IV) peptide; sixth row: a5(IV) peptide; and seventh row: a6(IV) peptide. Nonimmune serum (7 
wells in lane 1), monoclonal antibodies of Hll (lane 2), H21  (lane 3), H31  (lane 4), H43 (lane 5), H52 (lane 6), H63 (lane 7), and dH20 
(lane 8) were added to the wells individually  and incubated for 1 h. After the unbound antibodies had been washed out, the individual wells 
were blocked with bovine serum albumin. The peroxidase-conjugated secondary antibodies were added to all of the wells and reacted for 
1 h. Note the specific reactions between the antigens and antibodies even though there is some similar sequence between peptide sequences 
used for raising the monoclonal antibodies. 
lar to that of the other known e~ chains of collagen IV, we 
digested away the central collagenous domain by bacterial 
collagenase; and the materials were then electrophoresed 
and  transferred  to  PVDF  membranes.  The  membrane 
strips containing the blotted protein were incubated with 
antibody  H63  made  against  the  c~6(IV)-derived peptide 
(see Materials and Methods). As shown in Fig. 3, the anti- 
serum stained a band of ~27 kD in size, which is consistent 
with the NC1  size of the cDNA-derived u6(IV): 228 resi- 
dues  with  a  calculated molecular weight  of 25,418  (Oo- 
hashi et al., 1994). This staining was blocked by preincuba- 
tion of the  antiserum with  the  antigen  (data not  shown). 
Preimmune  serum  was  completely  negative.  When  the 
other five antibodies against cd(IV) through a5(IV) pep- 
tides were reacted as controls with the same materials, sev- 
eral bands  similar in size to  those  seen with c~6(IV) sera 
and  relatively distinct  bands  detected  by  t~l  to  c~5  sera 
were  obtained. The  size of these  bands was  also reason- 
Figure 3.  Western-blot anal- 
ysis  for  the  NCl-domain 
fraction from renal basement 
membrane. The NCl-domain 
fraction  was  prepared  from 
renal  basement  membrane 
(see Materials and Methods), 
and  SDS-PAGE  was  con- 
ducted  on  11.5%  polyacryl- 
amide gels. After blotting of 
the  proteins  onto  a  PVDF 
membrane,  the  membrane 
was  sliced into  seven  strips. 
Lanes 1 and 8 were stained with Coomasie-Brilliant  Blue, and the 
rest of them were incubated with the individual a  chain-specific 
monoclonal antibodies. Lanes 2-7 were incubated with Hll, H21, 
H31, H43, H52, and H63, respectively. Note the sizes of the reac- 
tive peptides are different from strip to strip. The sizes of the pep- 
tides for lane 6 (for a5(IV)NC1) and 7 (for a6(IV)NC1) are esti- 
mated as ~26 and 27 kD, respectively. Several reactive peptides 
around the size of 50 kD probably represent dimerized forms. 
able for each  NC1  domain.  Each  antibody also detected 
some  bands  at  ~50  kDa,  which  we  consider  to  be  the 
dimeric forms (Johansson et al., 1992). Thus, a6(IV) anti- 
body reacted indeed with the NC1  domain of the a6(IV) 
polypeptide, which is the first demonstration of the pres- 
ence of the polypeptide in human kidney. 
Indirect Immunofluorescence Staining of Kidney 
Basement Membranes with Monoclonal Antibody 
against ~6(IV)-derived Peptide 
Immunofluorescence studies on frozen sections of human 
adult  kidney with  the  c~6(IV)  peptide  antiserum  surpris- 
ingly gave a negative reaction in the glomerular basement 
membrane, whereas the basement membrane of the Bow- 
man's capsules and of some tubules was positive, as shown 
in Fig. 4 F. The staining was completely blocked by prein- 
cubation of the antibody with the ct6(IV) peptide used for 
raising antibody, H63  (Fig. 5 B). This staining pattern was 
quite in contrast with that obtained with the c~5(IV) pep- 
tide antiserum (Fig. 4  E), in which basement membranes 
of glomerulus, Bowman's capsules, and some tubules were 
all positive. Thus,  the two genes  COL4A5  and COL4A6, 
controlled by a  bidirectional promoter, are not always ex- 
pressed at the same time; the cells that produce glomerular 
basement membrane express the c~5(IV) gene but not the 
c~6(IV) one at least in adult humans.  Control experiments 
confirmed the specificity of these staining reactions. No re- 
action  was  obtained  with  the  preimmune  sera  (data  not 
shown).  In  contrast,  antisera  against cO(IV)  and  oL2(IV) 
peptides gave a  strong and similar staining pattern of all 
basement membranes of the glomeruli, tubules, and Bow- 
man's capsules as well (Fig. 4, A  and B). Intriguingly, the 
staining pattern for c~3(IV) and et4(IV) antibodies was the 
same;  both  strongly  stained  the  glomerular  basement 
membrane and some distal tubules but mostly gave faintly 
positive reactions for basement membranes of Bowman's 
capsules  (Fig. 4,  C  and  D).  The  staining pattern  for  the 
kidney is summarized in Table I. 
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bodies were used to stain kidney basement membranes. Antibodies of Hll, H21, H31, H43, H52, H63, and H64 were used for photos 
A-F, respectively. Note that cd(IV) and c~2(IV) chains are coexpressed in all of the basement membranes in the kidney: glomeruli, Bow- 
man's capsu!es,  distal  tubules, proximal tubules, and some capillaries.  Antibodies specific for c~3(IV) and a4(IV) chains demonstrated 
rather restricted staining pattern, i.e., glomerular, some tubular basement membranes; however these two chains are expressed together. 
Interestingly, c~5(IV) and a6(IV) chains are not coexpressed; no staining for ~6(IV) chain is seen in glomerular basement membrane 
(F), whereas c~5(IV) chains are clearly expressed in the glomerulus (E). 
To confirm that the monoclonal antibodies are recogniz- 
ing the e~6(IV) chain, we have done two experiments.  One 
of them was to define  the epitopes  of the H61, H62, and 
H63  antibodies  using  Geysen's technique  (Geysen et  al., 
1987).  As  mentioned  above,  the  epitope  sequences  of 
VSETLK, FGEL, and GELP for H61, H62, and H63 anti- 
bodies,  respectively,  were  all within the original peptide 
sequence but different from each other. However, the im- 
munostaining pattern  using the antibodies  for the kidney 
sections were the same  (data  not shown). This  suggested 
that the different antibodies recognizing different epitopes 
were reacting with the same molecule. The second experi- 
ment was to raise monoclonal antibodies to the peptide se- 
quence within the COL1 domain of the a6(IV) chain. We 
selected CPSTGELEFMGFPKG in the third imperfection 
of the GIy-X-Y repeating sequence (Oohashi et al., 1994) 
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Basement Membranes 
al(IV)  a2(IV)  a3(1v)  a4(1v)  c~5((v)  a6(1v) 
Glomerular BM  + +  + +  + + +  + + +  + +  - 
Mesangium  + +  + +  .... 
Bowman's BM  +++  +++  _+  -+  ++  ++ 
Tubular BM  ++  ++  ++*  ++*  ++*  ++* 
Capillary BM  +  +  .... 
+, weakly  positive; + +, moderately  positive; + + +, strongly  positive; -, negative. 
*  Not all the tubular basement  membrances  were positive  for  c~3(IV),  a4(IV), a5(IV), 
and a6(IV)  antibodies. 
within  the  COL1  domain.  Among  11  positive  clones  by 
ELISA, the two clones, H64 and H65, were subcloned and 
purified.  The immunostaining pattern for the kidney sec- 
tion using these  two clones was the same  as  that  of H63 
shown in Fig.  5. These  results  indicate  that  the  different 
antibodies  derived from the  different  sequences  still rec- 
ognize the same material, the a6(IV) chain, in the tissues. 
Differential Localization of the a5(IV) and a6(IV) 
Chains in Tissues Outside of the Kidney 
To  investigate  whether  the  two  genes  are  expressed  in 
basement membranes in tissues other than the kidney, we 
stained several other organs and tissues, as shown in Fig. 6. 
Skin. Epidermal  basement  membranes  are  thought  to 
be produced by the keratinocytes,  aligning at the base  of 
the  epithelial  layers.  Since  the  staining  pattern  for  the 
cd(IV) and ct2(IV) chains were almost the same, only the 
ct2 staining pattern is shown in Fig. 6 A. As shown in Fig. 5, 
B and C, this basement membrane was stained by both an- 
tibodies against ct5(IV) and c~6(IV) chains, indicating that 
the  keratinocytes  express  both  genes  together  in  human 
adult skin. 
Muscle. Esophageal smooth muscle, cardiac muscle, and 
abdominal  skeletal  muscle were  examined  by using anti- 
al(IV),  -c~2(IV),  -a5(IV),  and  -a6(IV)  antibodies.  Both 
a5(IV)  and  a6(IV)  chains  colocalized  in  the  basement 
membranes of the smooth muscle cells  (Fig. 6, E  and F). 
However, these two chains were never detected in cardiac 
muscle cells  (Fig.  6, H  and I), although both al(IV)  and 
a2(IV) chains were stained substantially (Fig. 6 G). Unex- 
pectedly, in basement membranes surrounding  the skele- 
tal  muscle  cells,  et5(IV)  was  negative  and  a6(IV)  was 
weakly positive (Fig. 6 L) when the sections were stained 
with H-61 antibody. Further,  this staining was blocked by 
incubating the antibody with the synthetic peptide  of the 
c~6(IV) chain. Relative to the a2(IV) staining, the c~6 stain- 
ing  intensity  was  quite  weak;  therefore  the  level  of the 
c~6(IV) chain is presumed to be fairly low. 
Adipocytes. Adipocytes  expressed  both  al(IV)  and 
e~2(IV)  chains  strongly  (Fig.  6  M).  Since  aS(IV)  and 
a6(IV) staining was quite low (Fig. 6, N  and O), we had to 
expose the film longer to get a clear staining pattern. The 
level of e~5(IV) and a6(IV) expression around adipocytes 
also thus appears to be quite low. 
Liver. cx2(IV)  chain  was  present  in  the  space  of Disse 
(Fig.  6  P);  however,  neither  a5(IV)  nor  ~6(IV)  chains 
were detected in this space underneath  the sinusoidal en- 
dothelial cells (Fig. 5, Q  and R). 
Table  II provides  a  summary of the  above-mentioned 
staining patterns. 
aS(IV) and a6(IV) Chains in Basement Membranes of 
Alport's Syndrome Patient 
Immunohistochemical  analysis  was  performed  in  kidney 
and skin from patients  with X-linked Alport's syndrome. 
As shown in Fig. 7, antibodies  against al(IV)  (photo not 
shown) and a2(IV) chains clearly stained basement mem- 
branes  in  glomeruli,  Bowman's  capsules,  and  tubules. 
However, neither of the antibodies against the a5(IV) and 
a6(IV)  chains  stained  the  basement  membranes  in  the 
Alport  kidney  (Fig.  7,  B  and  C).  Antibodies  against 
Figure  5.  Staining  of  kidney 
basement  membranes  by 
c~6(IV) antibodies.  Serial  sec- 
tions  of  human  kidney  were 
stained by the two monoclonal 
antibodies to the different part 
of the a6(IV) chain: one (H63) 
is to the synthetic peptide from 
the  NC1  domain  (A)  and  the 
other (H65) is to the COL do- 
main  (C).  Note  the  staining 
pattern  using  the  two  mono- 
clonal antibodies  is the  same. 
Positive  fluorescence  staining 
using  H63 antibody was com- 
pletely blocked by the original 
synthetic  peptide,  TTVEER- 
QQFGELPVSETLKAGQLH- 
TRV(B).  D  shows nonstained 
phase contrast microscopic im- 
age of the neighboring section. 
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a5(IV), a6(IV) Chains in Basement Membranes of Extrarenal 
Tissues 
a 1  (IV)  c~2(IV)  c~5(IV)  a6(IV) 
Skin  +++  +++  +++  +++ 
Muscle 
Skeletal muscle  +  +  +  +  -  + 
Cardiac muscle  +  +  +  +  -  - 
Smooth muscle  +  +  +  +  +  +  +  + 
Adipocyte  +  +  +  +  +  + 
Liver  +  +  -  - 
+, weakly positive; + +, moderately positive; + + +, strongly positive; -, negative. 
a3(IV) and a4(lV) chains also did not give positive stain- 
ing in basement membranes in the kidney of the two pa- 
tients examined (data not shown). 
In Fig. 8, distribution of a(IV) chains in skin specimens 
from a normal individual and an Alport patient is shown. 
Antibodies  against  al(IV)  and  a2(IV)  chains  demon- 
strated a clear linearized staining pattern in the epidermal 
basement  membrane  and  basement  membranes  around 
capillaries  and  sweat glands  in normal skin.  a5(IV)  and 
a6(IV) chains were detected only in the basement mem- 
brane of the  epidermis but not in  basement membranes 
around capillaries and sweat glands. In contrast to the nor- 
mal  skin,  Alport  skin  showed  negative  staining  with 
c~5(IV)  (Fig. 8 H) and a6(lV)  (Fig. 8/) antibodies in epi- 
dermal basement membranes, whereas cd(IV)  (data not 
shown)  and a2(IV)  (Fig.  8  G) antibodies clearly stained 
the basement membranes. 
Discussion 
Diversity has been revealed among the subunits that form 
collagen IV molecules with the discovery of the cx3, ct4, et5, 
and cx6 chains(Hudson et al., 1993). But chain assemblies 
that  make  up  type  IV molecules  have  been  difficult  to 
demonstrate since the c~3-a6(IV) chains were studied pri- 
marily in the context of the disease-related human tissues. 
The cx3(IV) chain was discovered as the Goodpasture anti- 
gen, which attacks primarily the alveolar basement mem- 
branes  in  the  lung  and  the  glomerular basement  mem- 
branes  in  the  kidney  (Butkowski  et  al.,  1987).  Further, 
trials to purify the cx3(IV) chain resulted in the discovery 
of another a-chain,  a4(IV)(Gunwar et al.,  1990).  cDNA 
cloning of these two chains led to the identification of mu- 
tations in COIAA3 and COL4A4 in patients with autoso- 
mal  recessive  type  Alport  syndrome  (Mochizuki  et  al., 
1994;  Lemmink et al., 1994).  Most recently COIAA6 was 
shown to be located next to COIAA5 (Zhou et al., 1993;. 
Sugimoto et al., 1994) and both genes were mutated in sev- 
eral X-linked cases of Alport syndrome combined with leio- 
myomatosis (Zhou et al., 1993). 
Immunohistochemical  analyses  have  shown  that  the 
al(IV)  and  a2(IV)  chains  are  abundant  in  all  tubular 
basement  membranes  and  in  the  glomerular  mesangial 
matrix (Kleppel et al., 1989).  However the a3-a5(IV) col- 
lagen chains  have a  rather limited distribution  in human 
tissues;  highly  enriched  in  glomerular  basement  mem- 
branes  but  found  only in  a  subset  of tubular  basement 
membranes (Hostikka et al., 1990; Sanes et al., 1990; Hud- 
son et al., 1992; Yoshioka et al., 1994). Just recently, Min- 
ers and Sanes (1994) reported the distribution  of a3, a4, 
and a5(IV) collagen chains in rodent basal laminae. They 
suggested from their immunohistochemical studies of vari- 
ous tissues that many combinations of a(IV) chains were 
possible,  but  a3  and  a4(IV)  chains  were  always  coex- 
pressed together, and appeared only in basal laminae that 
were a5(IV) chain positive. However, they did not exam- 
ine the distribution of the newly discovered et6(IV) chain 
with respect to the other a(IV) chains. In the light of gene 
regulation  of the  two  neighboring  genes,  COIAA5  and 
COIAA6, we herein examined and focused on the expres- 
sion of the two genes at the protein level. 
We first  raised  monoclonal  antibodies  specific for the 
human a6(IV) collagen chain and used them with antibod- 
ies  produced  by  a  previously isolated  clone  for  a5(IV) 
chain to identify location of a5(IV) and a6(IV) chains in 
basement membranes of kidney, skin, muscle, liver, and 
fat cells. In addition, we used the monoclonal antibodies to 
identify the NC1 domains of a5(IV) and a6(IV) by West- 
ern blotting. 
Our immunohistochemical survey with monoclonal anti- 
bodies to a5(IV) and a6(IV) chains  indicated  a  very re- 
stricted  distribution  of these proteins in basement mem- 
branes.  The  basement  membrane  in  the  glomerulus  is 
physiologically and  clinically  a  carefully  studied  matrix. 
This basement membrane contains  specialized structures 
that face cell layers of epithelial  cells and endothelia  or 
other cells on both surfaces. As shown in Fig. 4, the glom- 
erular basement membranes were strongly positive when 
stained  with  a5(IV)  chain-specific  antibody,  H51;  how- 
ever, antibody against the a6(IV) peptide did not show a 
fluorescence staining within the glomerular basement mem- 
brane.  In  contrast,  basement  membranes  in  Bowman's 
capsule and distal tubules were positive with both antibod- 
ies. There are at least two and possibly more different mo- 
lecular forms in the glomerulus: [al(IV)]2a2(IV) and one 
or more molecular forms of the combination of a3, a4, and 
a5  chains.  In  an  Alport's  nephritis  case,  neither  of the 
Figure 6.  Staining of basement membranes in extrarenal tissues using al(IV)/a2(IV), cx5(IV), and o~6(IV) antibodies.  Expression  of 
cd(IV), and a6(IV) chains was examined in basement membranes in extrarenal tissues; skin (A-C), smooth muscle cells (D-F), cardiac 
muscle cells (G-/), abdominal skeletal muscle cells (J-L), adipocytes  (M-O), and liver (P-R). Since antibodies  for al(IV) and a2(IV) 
chains gave quite similar patterns, only the a2(IV) staining pattern using H21 is shown in A, D, G, J, M, and P. Expression of a5(IV) (B, 
E, H, K, N, and Q, using H52 antibody) and a6(IV) (C, F, L L, O, and R, with H63 antibody) chains is compared in various basement 
membranes. Around the smooth muscle cells and at the epidermal/dermal junction,  the ~x5(IV) and c~6(IV) chains are coexpressed, but 
no expression  of these genes was detected in cardiac muscle and liver. Intriguingly,  only a6(IV) is weakly stained  in skeletal muscle, 
whereas no staining is detected for a5(IV) chain. 
Ninomiya et al, Tissue Distribution  of a5(IV) and ct6(lV) Collagen  Chains  1225 The Journal of Cell Biology, Volume 130,  1995  1226 Figure Z  Distribution of c~(IV)  chains in kidney from Alport's syndrome patient. Similar staining pattern was obtained with al(IV) (not 
shown) and c~2(IV) (A) antibodies, but no clear staining is shown in any basement membranes in the kidney sections stained with mono- 
clonal antibodies for a5(IV) (B, with H52) and c~6(IV) (C, with H63) chains. 
three chains, a3, or4, and a5, were found in the glomerulus 
(Fig. 6).  We do not know the  precise mutation of et(IV) 
gene in this  case. However, since more than 50 different 
mutations have been identified in the COL4A5  gene but 
none in the COL4A6 gene, it is possible that a  heterotri- 
meric molecule composed of the three chains, a3, a4, and 
e~5, cannot be formed due to  abnormal cd  chain synthe- 
sized from a mutated COL4A5 gene. 
In addition to the human and murine al(fV) and et2(IV) 
collagen genes (Killen et al., 1988;  Soininen  et al.,  1988), 
there are several clustered genes in vertebrates that are or- 
ganized in  a  head-to-head configuration and  directed by 
bidirectional  promoters.  These  include  the  histone  H2a 
and  H2b  genes  (Hentschel  and  Birnstiel,  1981),  DHFR 
and  mismatch repair  protein  1  gene  (Fujii  et  al.,  1992), 
Wilms' tumor locus  (Huang  et  al.,  1990),  a  proliferation 
cell nuclear antigen gene (Rizzo et al., 1990), an SV40-1ike 
monkey genomic  locus  (Saffer et  al.,  1984),  the  GPAT/ 
AIRC  genes  (Gavalas et  al.,  1993;  Gavalas and  Zalkin, 
1995),  and  Drosophila  ras2/rop  genes  (Lightfoot  et  al., 
1994).  Some of the promoters of these genes are bidirec- 
tional but the opposite genes are not identified. The pro- 
moter activity for one direction is quite different from that 
for  the  other  direction,  10-fold  different  in  some  cases 
(Gavalas and Zalkin, 1995).  Most of the paired genes are 
not  homologous  at  all,  however,  the  COL4A1/COL4A2 
and COL4A5/COL4A6 genes are homologous, indicating 
that the clusters did evolve by gene duplication. Divergent 
transcription  of the  two  genes  from a  bidirectional  pro- 
moter can thus provide coexpression and coregulation of 
expression in some tissues. Proximal cis-acting elements as 
well  as  trans-acting  factors  such  as  CTC  binding  factor 
(Fischer  et  al.,  1993)  have the  potential to modulate  the 
expression of both genes simultaneously. 
The genes for c~5(IV) and c~6(IV) chains are encoded on 
opposite DNA strands and have a common promoter re- 
gion (Sugimoto et al., 1994).  A  question that arose imme- 
diately when we noticed the specialized relation of these 
genes was  whether  these  genes  always produce  the  two 
chains at a steady rate as COL4A1 and COL4A2 genes do. 
As we demonstrated in Fig.  6,  keratinocytes, esophageal 
smooth muscle cells, fat ceils, striated muscle cells and pla- 
cental  epithelial  cells express a5(IV)  and  a6(IV)  genes, 
whereas hepatocytes and cardiac muscle cells do not ex- 
press either gene.  However, of interest  was that  skeletal 
muscle cells only synthesized  a6(IV)  chain  and  that  the 
glomerular basement membranes were positive with only 
with c~5(IV)  antibody in adult humans.  These results are 
consistent with the analysis of transcripts found in a vari- 
ety of tissues except for the heart (Zhou et al., 1993),  al- 
though we have not analyzed tissues from human fetuses. 
The two genes are transcribed in the opposite direction in 
a  tissue-specific manner, and regulation of expression for 
the two genes is controlled at the transcription level. One 
of the clues for the gene expression could be the presence 
of the  alternative  promoters on  the  COL4A6  gene  (Su- 
gimoto et al., 1994).  The two different transcription forms 
for the  c~6(IV)  gene driven by the  alternative promoters 
are found in  a  tissue-specific manner. The tissue-specific 
distribution  of the  newly discovered c~5(IV)  and  et6(IV) 
chains are probably related to the specialized function of 
individual basement membranes in different tissues. 
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Ninomiya et al. Tissue Distribution of a5(lV) and a6(IV) Collagen Chains  1227 Figure 8,  Distribution of a(IV)  chains in dermal basement membrane  from Alport syndrome patient.  Since a  similar staining pattern 
was obtained with cd(IV) and c~2(IV) antibodies in basement membranes of dermal epidermal junction and capillaries, only the c,2(IV) 
staining pattern  (A, with H21) is shown in normal skin. Both a5(IV)  (B, H52)  and a6(IV)  (C, H63)  antibodies stain only the dermal 
basement membrane  but not that of the capillaries.  In the Alport patient case, a  similar staining pattern was obtained for al(IV)  (not 
shown) and ~x2(IV) chains as in normal skin (G); however no clear staining was shown by monoclonal antibodies for ~5(IV)  (H)  and 
c~6(IV) (/) chains at all (H and/).  Phase-contrast images are shown for individual samples in normal skin (D-F) and Alport skin (J-L). 
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